Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 December 2022 | Story Jóhann Thormählen | Photo Anja Aucamp
Peter Makgato
Peter Makgato showed true perseverance in coming back after being out of action for more than a year with an Achilles tendon injury. The Kovsie long jumper won a bronze medal at the South African Championships in 2022.

If it wasn’t for Peter Makgato’s UFS support system, he would have been lost to South African athletics. The road of recovery after a serious injury can be lonesome, but he was never alone.

The promising long jumper had to learn to walk again after the injury to his Achilles tendon and could only compete more than a year after his dreams were shattered in November 2020.

Only months after returning to jumping in 2022, he was winning medals again.

Keeping me focused

“Without KovsieSport, I believe I would have hung up my spikes after that injury,” says Makgato. “Throughout the entire journey back, I had support from my coach (Emmarie Prinsloo; Head of KovsieSport Jumping Academy) and Oom DB (Prinsloo; Head of Athletics at KovsieSport).”

He also praises “the expert medical help” from Kovsie Health and says he went through nothing alone. “My progress was monitored by a team that knew me before the injury and this meant they were able to keep me focused on the progress and not on the injury.”

Although he had injuries before, Makgato says the emotional challenges were much bigger. “What really helped me were a few words from Wayde van Niekerk days after my operation when I went back to the track on crutches. He told me not to lose my head.

“That is the best advice you can give someone in my position. Physically I was broken, I had to make sure that mentally I fought to stay above the waters.”

Bigger goals in mind

He was only able to walk again from May 2021, started rehab in August 2021, and was running properly by December 2021.

He was only able to jump competitively again in March 2022, and a month later claimed a bronze medal at the South African Championships (7,47 m). This was followed by a USSA bronze in May 2022 (7,46 m).

“I had bigger goals in mind. Now that I look back, I realise that for a person who could not even run properly five months before and who had little preparation time, I was doing pretty good.”

And now the Master of Laws student has his sights on bigger things again: The World Athletics Championships next year and the Olympic Games in 2024.

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept